Top compounds associated with response to LINC00094


Feature Type Standardized
Nominal ANOVA
mRNA Panobinostat CCLE pan-cancer AAC -0.11 0.01
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.01
mRNA Doxorubicin gCSI pan-cancer AAC 0.13 0.01
mRNA prima-1 CTRPv2 pan-cancer AAC 0.08 0.01
mRNA pac-1 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.079 0.02
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.12 0.02
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC -0.13 0.02
mRNA paclitaxel FIMM pan-cancer AAC 0.32 0.02
Download CSV